Leukocyte subtyping predicts for treatment failure and poor survival in anal squamous cell carcinoma. Principe DR, Cataneo JL, Timbers KE, Koch RM, et al. BMC Cancer 2022;22:697.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Principe DR, Cataneo JL, Timbers KE, Koch RM, et al. Leukocyte subtyping predicts for treatment failure and poor survival in anal squamous cell carcinoma. BMC Cancer 2022;22:697.
PMID: 35751111